Predictors of Inadequate Serum Urate Response to Low-Dose Febuxostat in Male Patients with Gout
Wenyan Sun,1,* Xuetong Zhao,2- 4,* Nicola Dalbeth,5,* Robert Terkeltaub,6 Lingling Cui,1 Zhen Liu,1 Lin Han,1 Can Wang,1 Hui Zhang,1,7 Yiming Bao,2- 4 Changgui Li,1,7 Jie Lu1,7 1Shandong Provincial Key Laboratory of Metabolic Diseases, Shandong Provincial Clinical Research Ce...
Saved in:
Main Authors: | Sun W (Author), Zhao X (Author), Dalbeth N (Author), Terkeltaub R (Author), Cui L (Author), Liu Z (Author), Han L (Author), Wang C (Author), Zhang H (Author), Bao Y (Author), Li C (Author), Lu J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
by: Pang L, et al.
Published: (2023) -
Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat
by: Sheer R, et al.
Published: (2017) -
Treat-to-target (T2T) of serum urate (SUA) in gout: a clinical audit in real-world gout patients
by: C.L. Teh, et al.
Published: (2019) -
Febuxostat in the management of hyperuricemia and chronic gout: a review
by: Miao Hu, et al.
Published: (2008) -
Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review
by: Adwoa Dansoa Tabi-Amponsah, et al.
Published: (2023)